Pierre Jaquet

TL;DR: In this paper , the authors describe bleeding and thrombotic events and their risk factors in patients receiving extracorporeal membrane oxygenation (ECMO) for severe coronavirus disease 2019 (COVID-19) and evaluate their impact on in-hospital mortality.

TL;DR: In intensive care unit (ICU) settings, in which multiple-organ dysfunctions can occur rapidly, hemodialysis may be a viable option for maintaining remdesivir treatment, while improving tolerance, by removing both remdesvir’s metabolite (GS-441524) and sulfobutylether β-cyclodextrin sodium (SEBCD).

TL;DR: In this article, the authors reported electroencephalographic (EEG) findings of COVID-19 patients with various neurological symptoms, including focal or generalized slowing, interictal epileptic figures, seizures, or status epilepticus.

TL;DR: Standard EEG abnormalities recorded at time of VA-ECMO initiation are predictive of unfavorable outcomes, however, the low sensitivity of these parameters highlights the need for a multimodal evaluation for improving management of care and prognostication.